Literature DB >> 16693635

External Ophthalmoplegia, Pigmentary Degeneration of the Retina, and Cardiomyopathy: A Newly Recognized Syndrome.

T P Kearns1.   

Abstract

Entities:  

Year:  1965        PMID： 16693635      PMCID： PMC1310209     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  45 in total

1.  Chronic progressive ophthalmoplegia with extra-ocular extension (ocular myopathy).

Authors:  J H THIEL
Journal:  Folia Psychiatr Neurol Neurochir Neerl       Date:  1954-12

2.  Occurrence of retinal pigmentation, ophthalmoplegia, ataxia, deafness and heart block. Report of a case, with findings at autopsy.

Authors:  B V JAGER; H L FRED; R B BUTLER; W H CARNES
Journal:  Am J Med       Date:  1960-11       Impact factor: 4.965

3.  Progressive dystrophic external ophthalmoplegia with abiotrophic fundus changes.

Authors:  J C THORSON; W E BELL
Journal:  Arch Ophthalmol       Date:  1959-11

4.  A contribution to the electroretinogram of retinitis pigmentosa.

Authors:  A D RUEDEMANN; W K NOELL
Journal:  Am J Ophthalmol       Date:  1959-01       Impact factor: 5.258

5.  Analytic studies of the electromyogram of human extraocular muscle.

Authors:  G M BREININ
Journal:  Am J Ophthalmol       Date:  1958-09       Impact factor: 5.258

6.  Progressive dystrophy of the external eye muscles.

Authors:  W R KIRSCHBAUM; J J HOLLAND
Journal:  Neurology       Date:  1958-04       Impact factor: 9.910

7.  Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases.

Authors:  T P KEARNS; G P SAYRE
Journal:  AMA Arch Ophthalmol       Date:  1958-08

8.  Ocular myopathy with hypogonadism.

Authors:  P O Lundberg
Journal:  Acta Neurol Scand       Date:  1962       Impact factor: 3.209

9.  Progressive dystrophy of the external ocular muscles (ocular myopathy).

Authors:  L G KILOH; S NEVIN
Journal:  Brain       Date:  1951       Impact factor: 13.501

10.  Heredopathia atactica polyneuritiformis.

Authors:  H REESE; J BARETA
Journal:  J Neuropathol Exp Neurol       Date:  1950-10       Impact factor: 3.685
View more
  28 in total

1.  Plasma vitamin A and beta-carotene in retinitis pigmentosa.

Authors:  W H Massoud; A C Bird; E S Perkins
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

Review 2.  Chronic progressive external ophthalmoplegia.

Authors:  Andrew G Lee; Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

3.  Microcephaly-cardiomyopathy: a new autosomal recessive phenotype?

Authors:  I M Winship; D L Viljoen; P M Leary; M M De Moor
Journal:  J Med Genet       Date:  1991-09       Impact factor: 6.318

Review 4.  Ophthalmic eponyms from the Mayo Clinic.

Authors:  G B Bartley
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

5.  Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome.

Authors:  G Hübner; J M Gokel; D Pongratz; A Johannes; J W Park
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Histopathology of mitochondrial cytopathy and the Laurence-Moon-Biedl syndrome.

Authors:  P Runge; D Calver; J Marshall; D Taylor
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

7.  [Mitochondrial anomalies with peculiar distribution in a muscular dystrophy with pelvic onset (author's transl)].

Authors:  H Carrier; A Garde; M Tommasi; N Kopp; J F Savet
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

8.  Kearns' syndrome, a new form of cardiomyopathy.

Authors:  S C Uppal
Journal:  Br Heart J       Date:  1973-07

9.  ERG and VECP in chronic progressive external ophthalmoplegia (CPEO).

Authors:  H Berdjis; W Heider; K Demisch
Journal:  Doc Ophthalmol       Date:  1985-10-15       Impact factor: 2.379

10.  Congestive heart failure due to mitochondrial cardiomyopathy in Kearns-Sayre syndrome.

Authors:  F X Kleber; J W Park; G Hübner; A Johannes; D Pongratz; E König
Journal:  Klin Wochenschr       Date:  1987-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.